Skip to content
Clinical Trials – home

Spitalul Clinic de Copii “Dr. Victor Gomoiu”

Verified siteinfo

Romania Bulevardul Basarabia 21, 022102 Bucharest, Romania

  • 7 trials recruiting
  • Colitis ulcerative · Crohn's disease · Migraine
  • Adults and children

About Specializations

Spitalul Clinic de Copii “Dr. Victor Gomoiu” in Bucharest, Romania specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Migraine, Migraine with aura, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology

The medical center is at the forefront of neurology research, with a particular focus on pediatric conditions. The ongoing studies aim to enhance the understanding and treatment of neurological disorders in children and adolescents.

  • Episodic Migraine in Pediatric Patients

Through innovative research, the center is dedicated to improving the quality of life for young patients suffering from episodic migraine, exploring new therapeutic options to manage and alleviate symptoms effectively.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Bulevardul Basarabia 21022102 BucharestRomania
Recruiting now
7 trials
Conditions studied
7
Partner status
Verified site

More sites in BucharestRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

A study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years
  • Substances:Clemizole Hydrochloride
  • Sponsor:Epygenix Therapeutics Inc.

Colitis ulcerative+1

Recruiting

Long-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn's disease

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Vedolizumab
  • Sponsor:Takeda Development Center Americas Inc.

Study Comparing the Effects of Ozanimod and Fingolimod in Children and Adolescents with Relapsing Remitting Multiple Sclerosis

Registered drug
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Fingolimod
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Migraine+2

Recruiting

Study on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Migraine+2

Recruiting

Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Colitis ulcerative+1

Recruiting

Study of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn's Disease

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Vedolizumab
  • Sponsor:Takeda Development Center Americas Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.